U.S. flag

An official website of the United States government

NM_001271.4(CHD2):c.2699G>A (p.Arg900Gln) AND Developmental and epileptic encephalopathy 94

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Mar 19, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000679946.10

Allele description [Variation Report for NM_001271.4(CHD2):c.2699G>A (p.Arg900Gln)]

NM_001271.4(CHD2):c.2699G>A (p.Arg900Gln)

Gene:
CHD2:chromodomain helicase DNA binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q26.1
Genomic location:
Preferred name:
NM_001271.4(CHD2):c.2699G>A (p.Arg900Gln)
HGVS:
  • NC_000015.10:g.92978355G>A
  • NG_012826.2:g.83035G>A
  • NM_001271.4:c.2699G>AMANE SELECT
  • NP_001262.3:p.Arg900Gln
  • LRG_1425t1:c.2699G>A
  • LRG_1425:g.83035G>A
  • LRG_1425p1:p.Arg900Gln
  • NC_000015.9:g.93521585G>A
  • NG_012826.1:g.83035G>A
  • NM_001271.3:c.2699G>A
Protein change:
R900Q
Links:
dbSNP: rs1567149946
NCBI 1000 Genomes Browser:
rs1567149946
Molecular consequence:
  • NM_001271.4:c.2699G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Developmental and epileptic encephalopathy 94 (DEE94)
Synonyms:
Epileptic encephalopathy, childhood-onset
Identifiers:
MONDO: MONDO:0014150; MedGen: C3809278; Orphanet: 1942; Orphanet: 2382; OMIM: 615369

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000807380Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicunknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001575741Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Mar 19, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Molecular findings among patients referred for clinical whole-exome sequencing.

Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, Veeraraghavan N, Hawes A, Chiang T, Leduc M, Beuten J, Zhang J, He W, Scull J, Willis A, Landsverk M, Craigen WJ, Bekheirnia MR, et al.

JAMA. 2014 Nov 12;312(18):1870-9. doi: 10.1001/jama.2014.14601.

PubMed [citation]
PMID:
25326635
PMCID:
PMC4326249
See all PubMed Citations (4)

Details of each submission

From Baylor Genetics, SCV000807380.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001575741.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This missense change has been observed in individual(s) with clinical features of CHD2-related conditions (PMID: 25326635, 30525188). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 900 of the CHD2 protein (p.Arg900Gln). ClinVar contains an entry for this variant (Variation ID: 560973). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CHD2 protein function.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 25, 2024